LABCCIN Sanitizer Gel
- Manufacturer
- LCC LTD
- Effective date
- 2020-05-26
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:29:04
Label at a glance#
ProductLABCCIN Sanitizer Gel
Active ingredientALCOHOL
Label structure1 sections
Label contents#
Full prescribing information#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 77932-060-01 | 2023-03-08 | C162847 | 48780-1 | d6a99b39-a71e-a426-e053-dadaa90af4c2 | LABCCIN Sanitizer Gel 77932-060-01 |
| 77932-060-01 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-a71e-a426-e053-dadaa90af4c2 | LABCCIN Sanitizer Gel 77932-060-01 |
Products#
Every source-derived product name is available through these pages.
- LABCCIN Sanitizer Gel
- Ethyl Alcohol
- DIPROPYLENE GLYCOL
- CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE
- PEG-60 HYDROGENATED CASTOR OIL
- WATER
- ALCOHOL
- GLYCERIN
- AMINOMETHYLPROPANOL
- ALOE VERA LEAF
- PROPOLIS WAX
- GRAPEFRUIT
- GREEN TEA LEAF
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 77932-060 | 77932-060-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIPROPYLENE GLYCOL | E107L85C40 | IACT |
| CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE | 0A5MM307FC | IACT |
| PEG-60 HYDROGENATED CASTOR OIL | 02NG325BQG | IACT |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | ACTIB |
| GLYCERIN | PDC6A3C0OX | IACT |
| AMINOMETHYLPROPANOL | LU49E6626Q | IACT |
| ALOE VERA LEAF | ZY81Z83H0X | IACT |
| PROPOLIS WAX | 6Y8XYV2NOF | IACT |
| GRAPEFRUIT | O82C39RR8C | IACT |
| GREEN TEA LEAF | W2ZU1RY8B0 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f660fb92-bee7-7ce7-e053-2995a90a1e73 | a697db95-cfc5-67ad-e053-2a95a90a8eee | 2023-03-08 | a697db95-cfc5-67ad-e053-2a95a90a8eee |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
